Literature DB >> 1763802

The impact of endemic schistosomiasis on acute viral hepatitis.

Y A Ghaffar1, S A Fattah, M Kamel, R M Badr, F F Mahomed, G T Strickland.   

Abstract

One hundred forty-four of 166 adults with acute viral hepatitis (AVH) admitted to an Egyptian fever hospital were followed for 12 months. The hepatitis B surface antigen (HBsAg) carrier rate in 95 with hepatitis B virus (HBV) hepatitis decreased from 53% at three months to 13% at 12 months. At 12 months, 22% of the male patients had persistent HBsAg compared with only 7% of the female patients. The HBsAg carrier rate was 25% at 12 months in those with schistosomiasis compared with 9% in those with only acute HBV infection. Splenomegaly persisted in those with palpable spleens at the initial examination and others developed splenomegaly. The prevalence of splenomegaly increased from 11% on admission to 20% at 12 months in those with only AVH, and from 40% to 69% in those with concomitant schistosomiasis. Patients with concomitant schistosomiasis had higher mean values for liver function test results and a greater proportion had abnormal liver function test results during hospitalization and follow-up than those with AVH only. Concomitant schistosomiasis increased the prevalence and prolonged splenomegaly and morbidity due to AVH. Both male sex and concomitant schistosomiasis prolonged the HBsAg carrier state. We propose that AVH frequently converts uncomplicated intestinal schistosomiasis to hepatosplenic schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763802     DOI: 10.4269/ajtmh.1991.45.743

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

Review 1.  Curse of schistosomiasis on Egyptian liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

2.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

3.  Hepatitis B and Schistosoma co-infection in a non-endemic area.

Authors:  J Á Cuenca-Gómez; J Salas-Coronas; A B Lozano-Serrano; J Vázquez-Villegas; M J Soriano-Pérez; M Estévez-Escobar; A Villarejo-Ordóñez; M T Cabezas-Fernández
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-07       Impact factor: 3.267

4.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

Review 5.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

Review 6.  Gastrointestinal manifestations of schistosomiasis.

Authors:  G T Strickland
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

7.  Hepatocellular carcinoma in Egypt: a single center study over a decade.

Authors:  Abdel-Rahman el-Zayadi; Hanaa M Badran; Eman M F Barakat; Mohy el-Deen Attia; Sherine Shawky; Mostafa K Mohamed; Osaima Selim; Ahmed Saeid
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

8.  High prevalence of hepatitis C in Egyptian patients with chronic liver disease.

Authors:  I A Waked; S M Saleh; M S Moustafa; A A Raouf; D L Thomas; G T Strickland
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

9.  Chronic hepatitis in experimental schistosomiasis.

Authors:  Z A Andrade; A W Cheever
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens.

Authors:  Tom Van Gool; Hans Vetter; Tony Vervoort; Michael J Doenhoff; Jose Wetsteyn; David Overbosch
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.